Neuraxis (NRXS) Preferred Dividend Payments (2024 - 2025)
Neuraxis (NRXS) posted Preferred Dividend Payments of $194882.0 for Q4 2025, down 1.92% sequentially from $198707.0 in Q3 2025, and up 17.08% YoY from $166448.0 in Q4 2024.
Neuraxis (NRXS) Preferred Dividend Payments (2024 - 2025) Analysis & Trends
Neuraxis has reported Preferred Dividend Payments for 2 years, with the latest figure at $194882.0 in Q4 2025.
- Quarterly Preferred Dividend Payments rose 17.08% year-over-year to $194882.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $814597.0 (changed N/A YoY) and the FY2025 annual result came in at $814597.0, up 285.58% from the prior year.
- Preferred Dividend Payments slipped to $194882.0 in Q4 2025 per NRXS's latest filing, from $198707.0 in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $213543.0 in Q1 2025 and troughed at $44820.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Neuraxis | 75.51 Mn | 67.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 194,882.00 |
| Sep 30, 2025 | 198,707.00 |
| Jun 30, 2025 | 207,465.00 |
| Mar 31, 2025 | 213,543.00 |
| Dec 31, 2024 | 166,448.00 |
| Sep 30, 2024 | 44,820.00 |